Joseph E. Blaney

3.4k total citations · 1 hit paper
48 papers, 2.7k citations indexed

About

Joseph E. Blaney is a scholar working on Infectious Diseases, Virology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Joseph E. Blaney has authored 48 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Infectious Diseases, 23 papers in Virology and 22 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Joseph E. Blaney's work include Mosquito-borne diseases and control (22 papers), Viral Infections and Vectors (20 papers) and Viral Infections and Outbreaks Research (18 papers). Joseph E. Blaney is often cited by papers focused on Mosquito-borne diseases and control (22 papers), Viral Infections and Vectors (20 papers) and Viral Infections and Outbreaks Research (18 papers). Joseph E. Blaney collaborates with scholars based in United States, Canada and Norway. Joseph E. Blaney's co-authors include Brian R. Murphy, Stephen S. Whitehead, Anna P. Durbin, Christopher T. Hanson, Kathryn A. Hanley, Peter B. Jahrling, Julie H. McArthur, Cai-Yen Firestone, Reed F. Johnson and Jennifer M. Matro and has published in prestigious journals such as PLoS ONE, Nature Reviews Microbiology and Journal of Virology.

In The Last Decade

Joseph E. Blaney

48 papers receiving 2.7k citations

Hit Papers

Prospects for a dengue virus vaccine 2007 2026 2013 2019 2007 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Prospects for a dengue virus vaccine
    2007 477 citations Stephen S. Whitehead, Joseph E. Blaney et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph E. Blaney United States 29 1.8k 1.8k 607 560 374 48 2.7k
Lewis Markoff United States 28 1.4k 0.8× 1.8k 1.0× 571 0.9× 339 0.6× 394 1.1× 42 2.4k
Claire Y.‐H. Huang United States 31 2.2k 1.3× 2.6k 1.5× 267 0.4× 202 0.4× 234 0.6× 63 2.9k
Myrna C. Bonaldo Brazil 26 1.1k 0.6× 1.6k 0.9× 835 1.4× 137 0.2× 380 1.0× 72 2.2k
Thomas J. Chambers United States 22 2.0k 1.1× 2.6k 1.4× 526 0.9× 321 0.6× 252 0.7× 33 3.2k
Alison J. Johnson United States 24 3.1k 1.7× 3.5k 2.0× 894 1.5× 373 0.7× 245 0.7× 38 4.3k
Thaneeya Duangchinda Thailand 17 2.2k 1.3× 2.4k 1.4× 396 0.7× 204 0.4× 250 0.7× 34 3.0k
Hugues Tolou France 27 2.1k 1.2× 2.5k 1.4× 257 0.4× 173 0.3× 197 0.5× 64 2.9k
David Warrilow Australia 27 1.1k 0.6× 949 0.5× 263 0.4× 397 0.7× 335 0.9× 67 1.8k
Katherine L. Williams United States 17 1.5k 0.8× 1.6k 0.9× 257 0.4× 284 0.5× 146 0.4× 23 2.1k
Kanakatte Raviprakash United States 27 1.5k 0.8× 1.3k 0.7× 337 0.6× 159 0.3× 238 0.6× 47 2.1k

Countries citing papers authored by Joseph E. Blaney

Since Specialization
Citations

This map shows the geographic impact of Joseph E. Blaney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph E. Blaney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph E. Blaney more than expected).

Fields of papers citing papers by Joseph E. Blaney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph E. Blaney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph E. Blaney. The network helps show where Joseph E. Blaney may publish in the future.

Co-authorship network of co-authors of Joseph E. Blaney

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph E. Blaney. A scholar is included among the top collaborators of Joseph E. Blaney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph E. Blaney. Joseph E. Blaney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dyall, Julie, Reed F. Johnson, Svetlana I. Chefer, et al.. (2017). [ 18 F]-Fluorodeoxyglucose Uptake in Lymphoid Tissue Serves as a Predictor of Disease Outcome in the Nonhuman Primate Model of Monkeypox Virus Infection. Journal of Virology. 91(21). 12 indexed citations
2.
Kurup, Drishya, Amy B. Papaneri, Christoph Wirblich, et al.. (2015). Preclinical Development of Inactivated Rabies Virus–Based Polyvalent Vaccine Against Rabies and Filoviruses. The Journal of Infectious Diseases. 212(suppl 2). S414–S424. 43 indexed citations
3.
Dodd, Lori E., Reed F. Johnson, Joseph E. Blaney, & Dean Follmann. (2014). Matched Longitudinal Analysis of Biomarkers Associated with Survival. Clinical and Vaccine Immunology. 21(8). 1145–1152. 1 indexed citations
4.
Papaneri, Amy B., John G. Bernbaum, Joseph E. Blaney, et al.. (2014). Controlled viral glycoprotein expression as a safety feature in a bivalent rabies-ebola vaccine. Virus Research. 197. 54–58. 7 indexed citations
5.
Song, Haifeng, Nicole Josleyn, Krisztina Janosko, et al.. (2013). Monkeypox Virus Infection of Rhesus Macaques Induces Massive Expansion of Natural Killer Cells but Suppresses Natural Killer Cell Functions. PLoS ONE. 8(10). e77804–e77804. 61 indexed citations
6.
Blaney, Joseph E., Andrea Marzi, Amy B. Papaneri, et al.. (2013). Antibody Quality and Protection from Lethal Ebola Virus Challenge in Nonhuman Primates Immunized with Rabies Virus Based Bivalent Vaccine. PLoS Pathogens. 9(5). e1003389–e1003389. 95 indexed citations
7.
Brandt, Curtis R., et al.. (2012). Antiviral activity of the EB peptide against zoonotic poxviruses. Virology Journal. 9(1). 6–6. 17 indexed citations
8.
Kindrachuk, Jason, Ryan J. Arsenault, Anthony Kusalik, et al.. (2011). Systems Kinomics Demonstrates Congo Basin Monkeypox Virus Infection Selectively Modulates Host Cell Signaling Responses as Compared to West African Monkeypox Virus. Molecular & Cellular Proteomics. 11(6). M111.015701–M111.015701. 61 indexed citations
9.
Johnson, Reed F., Srikanth Yellayi, Jennifer Cann, et al.. (2011). Cowpox virus infection of cynomolgus macaques as a model of hemorrhagic smallpox. Virology. 418(2). 102–112. 26 indexed citations
10.
Smith, Alvin L., Julie Dyall, Reed F. Johnson, et al.. (2011). Inhibition of cowpox virus and monkeypox virus infection by mitoxantrone. Antiviral Research. 93(2). 305–308. 19 indexed citations
11.
Johnson, Reed F., Julie Dyall, Dan R. Ragland, et al.. (2010). Comparative Analysis of Monkeypox Virus Infection of Cynomolgus Macaques by the Intravenous or Intrabronchial Inoculation Route. Journal of Virology. 85(5). 2112–2125. 69 indexed citations
12.
Blaney, Joseph E., Anna P. Durbin, Brian R. Murphy, & Stephen S. Whitehead. (2009). Targeted Mutagenesis as a Rational Approach to Dengue Virus Vaccine Development. Current topics in microbiology and immunology. 338. 145–158. 9 indexed citations
13.
Blaney, Joseph E., Laura Goddard, Christopher T. Hanson, et al.. (2008). Dengue virus type 3 vaccine candidates generated by introduction of deletions in the 3′ untranslated region (3′-UTR) or by exchange of the DENV-3 3′-UTR with that of DENV-4. Vaccine. 26(6). 817–828. 90 indexed citations
14.
15.
Blaney, Joseph E., Anna P. Durbin, Brian R. Murphy, & Stephen S. Whitehead. (2006). Development of a Live Attenuated Dengue Virus Vaccine Using Reverse Genetics. Viral Immunology. 19(1). 10–32. 82 indexed citations
16.
Blaney, Joseph E., Christopher T. Hanson, Kathryn A. Hanley, Brian R. Murphy, & Stephen S. Whitehead. (2004). Vaccine candidates derived from a novel infectious cDNA clone of an American genotype dengue virus type 2. BMC Infectious Diseases. 4(1). 39–39. 64 indexed citations
17.
18.
19.
20.
Harhaj, Edward W., Joseph E. Blaney, Scott Millhouse, & Shao‐Cong Sun. (1996). Differential Effects of IκB Molecules on Tat-Mediated Transactivation of HIV-1 LTR. Virology. 216(1). 284–287. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lewis Markoff Breakdown of academic impact, for papers by Claire Y.‐H. Huang Breakdown of academic impact, for papers by Myrna C. Bonaldo Breakdown of academic impact, for papers by Thomas J. Chambers Breakdown of academic impact, for papers by Alison J. Johnson Breakdown of academic impact, for papers by Thaneeya Duangchinda Breakdown of academic impact, for papers by Hugues Tolou Breakdown of academic impact, for papers by David Warrilow Breakdown of academic impact, for papers by Katherine L. Williams Breakdown of academic impact, for papers by Kanakatte Raviprakash
Rankless by CCL
2026